Virus Genome Detection - SARS-CoV-2 sequence analysis (417)

Campioni:

3-5 samples of 1.5 ml

Proprietà campione:

Lyophilized cell culture supernatants (inactivated)

Informazioni sulla spedizione:

Shipping at ambient temperature

Parametri:

Differentiation of SARS-CoV-2 variants with clinical relevance using whole genome sequencing Please note: Starting in 2024, only results of SARS-CoV-2 sequence analyses for SARS-CoV-2 variants with clinical relevance will be considered in this EQA program. Results from point mutation analyses can no longer be submitted and evaluated

Validità del certificato:

12 months

Avviso di sicurezza:

Process as patient sample material

Informazioni aggiuntive:

Cooperation with: Nationales Konsiliarlabor für Coronaviren, Institut für Virologie, Charité – Universitätsmedizin Berlin; Medizinisches Infektiologiezentrum Berlin; Abt. Methodenentwicklung und Forschungsinfrastruktur, Robert Koch-Institut, Berlin

Esperto EQAS: